June 16, 2022
Life Sciences
  • Moderna Inc. is planning to test its COVID-19 vaccine in babies 3 months to 6 months old, the youngest age group studied to date. The biotech company said it is in the final stages of planning the “BabyCove” study and expects to begin enrolling as many as 700 babies in September. BabyCove would be the first study of Moderna’s vaccine in infants younger than 6 months. (Article here)